FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080474268> ?p ?o ?g. }

• W3080474268 abstract "Purposes: To measure expression levels of CD47 during endometrial carcinoma development, and to determine specific modulatory effects. Methods: CD47 expression levels in endometrial carcinoma tissues and adjacent tissues were analyzed using qRT-PCR. CD47-overexpressed or downregulated cell models were established using CD47 plasmid or CD47 shRNA. The effects of CD47 on HEC-1A and Ishikawa cell growth were evaluated using CCK-8 assays. Migration ability of transfected HEC-1A and Ishikawa cells were examined using wound healing assays. Flow cytometry was used to measure the effects of CD47 on apoptosis and the cell cycle in HEC-1A and Ishikawa cells. Western blot was used to analyze the correlation between CD47 expression level and PI3K/Akt/mTOR signaling pathway. Results: Highly expressed CD47 was observed in endometrial carcinoma tissues, with higher levels in more advanced tissues than in early tissues. Upregulation of CD47 enhanced cell viability and migration ability in HEC-1A and Ishikawa cells, while silencing CD47 caused the opposite results. CD47 overexpression suppressed apoptosis and inhibited cell cycle arrest in HEC-1A and Ishikawa cells. CD47 upregulation contributes to the activation of PI3K/Akt/mTOR signaling pathway in endometrial carcinoma cells. Conclusion: CD47 exerts oncogenic functions in endometrial carcinoma by activating PI3K/Akt/mTOR signaling, suggesting it may be a novel immunotherapeutic target for therapeutic interventions." @default.
• W3080474268 created "2020-09-01" @default.
• W3080474268 creator A5003065832 @default.
• W3080474268 creator A5003448819 @default.
• W3080474268 creator A5039520635 @default.
• W3080474268 creator A5065081259 @default.
• W3080474268 creator A5067485668 @default.
• W3080474268 creator A5068521150 @default.
• W3080474268 creator A5087472916 @default.
• W3080474268 date "2020-08-26" @default.
• W3080474268 modified "2023-09-27" @default.
• W3080474268 title "CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway" @default.
• W3080474268 cites W1757407923 @default.
• W3080474268 cites W1966981965 @default.
• W3080474268 cites W2009886463 @default.
• W3080474268 cites W2016513136 @default.
• W3080474268 cites W2017181626 @default.
• W3080474268 cites W2021605685 @default.
• W3080474268 cites W2041944081 @default.
• W3080474268 cites W2048370264 @default.
• W3080474268 cites W2087861588 @default.
• W3080474268 cites W2121042742 @default.
• W3080474268 cites W2152764747 @default.
• W3080474268 cites W2157079036 @default.
• W3080474268 cites W2171374349 @default.
• W3080474268 cites W2414564534 @default.
• W3080474268 cites W2414840542 @default.
• W3080474268 cites W2432531102 @default.
• W3080474268 cites W2529821982 @default.
• W3080474268 cites W2570618306 @default.
• W3080474268 cites W2592953803 @default.
• W3080474268 cites W2594014934 @default.
• W3080474268 cites W2603831404 @default.
• W3080474268 cites W2605076107 @default.
• W3080474268 cites W2739567284 @default.
• W3080474268 cites W2750919339 @default.
• W3080474268 cites W2783531913 @default.
• W3080474268 cites W2801298049 @default.
• W3080474268 cites W2894315674 @default.
• W3080474268 cites W2899600912 @default.
• W3080474268 cites W2905793058 @default.
• W3080474268 cites W2910165589 @default.
• W3080474268 cites W2991210834 @default.
• W3080474268 cites W4238567307 @default.
• W3080474268 cites W4242982114 @default.
• W3080474268 cites W4294214970 @default.
• W3080474268 doi "https://doi.org/10.3389/fonc.2020.01525" @default.
• W3080474268 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7479237" @default.
• W3080474268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32984001" @default.
• W3080474268 hasPublicationYear "2020" @default.
• W3080474268 type Work @default.
• W3080474268 sameAs 3080474268 @default.
• W3080474268 citedByCount "16" @default.
• W3080474268 countsByYear W30804742682021 @default.
• W3080474268 countsByYear W30804742682022 @default.
• W3080474268 countsByYear W30804742682023 @default.
• W3080474268 crossrefType "journal-article" @default.
• W3080474268 hasAuthorship W3080474268A5003065832 @default.
• W3080474268 hasAuthorship W3080474268A5003448819 @default.
• W3080474268 hasAuthorship W3080474268A5039520635 @default.
• W3080474268 hasAuthorship W3080474268A5065081259 @default.
• W3080474268 hasAuthorship W3080474268A5067485668 @default.
• W3080474268 hasAuthorship W3080474268A5068521150 @default.
• W3080474268 hasAuthorship W3080474268A5087472916 @default.
• W3080474268 hasBestOaLocation W30804742681 @default.
• W3080474268 hasConcept C104317684 @default.
• W3080474268 hasConcept C127561419 @default.
• W3080474268 hasConcept C1491633281 @default.
• W3080474268 hasConcept C185592680 @default.
• W3080474268 hasConcept C190283241 @default.
• W3080474268 hasConcept C203014093 @default.
• W3080474268 hasConcept C2780104668 @default.
• W3080474268 hasConcept C29537977 @default.
• W3080474268 hasConcept C502942594 @default.
• W3080474268 hasConcept C53227056 @default.
• W3080474268 hasConcept C553184892 @default.
• W3080474268 hasConcept C55493867 @default.
• W3080474268 hasConcept C62112901 @default.
• W3080474268 hasConcept C62478195 @default.
• W3080474268 hasConcept C75217442 @default.
• W3080474268 hasConcept C86554907 @default.
• W3080474268 hasConcept C86803240 @default.
• W3080474268 hasConcept C95444343 @default.
• W3080474268 hasConceptScore W3080474268C104317684 @default.
• W3080474268 hasConceptScore W3080474268C127561419 @default.
• W3080474268 hasConceptScore W3080474268C1491633281 @default.
• W3080474268 hasConceptScore W3080474268C185592680 @default.
• W3080474268 hasConceptScore W3080474268C190283241 @default.
• W3080474268 hasConceptScore W3080474268C203014093 @default.
• W3080474268 hasConceptScore W3080474268C2780104668 @default.
• W3080474268 hasConceptScore W3080474268C29537977 @default.
• W3080474268 hasConceptScore W3080474268C502942594 @default.
• W3080474268 hasConceptScore W3080474268C53227056 @default.
• W3080474268 hasConceptScore W3080474268C553184892 @default.
• W3080474268 hasConceptScore W3080474268C55493867 @default.
• W3080474268 hasConceptScore W3080474268C62112901 @default.
• W3080474268 hasConceptScore W3080474268C62478195 @default.
• W3080474268 hasConceptScore W3080474268C75217442 @default.
• W3080474268 hasConceptScore W3080474268C86554907 @default.
• W3080474268 hasConceptScore W3080474268C86803240 @default.

• next